Drug treatment of depression in HIV-positive patients : safety considerations (Q36239606)

13 August 2017

1 reference

title

Drug treatment of depression in HIV-positive patients : safety considerations (English)

1 reference

13 August 2017

2

Glenn J Treisman

1 reference

13 August 2017

Andrew A Pieper

1

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

28

1 reference

13 August 2017

753-762

1 reference

13 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200528090-00002

13 August 2017

0 references

cites work

General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era.

1 reference

12 December 2020

Pharmacokinetics and bioavailability of zidovudine in humans

1 reference

12 December 2020

Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial

1 reference

12 December 2020

Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients

1 reference

12 December 2020

Progression to AIDS: the effects of stress, depressive symptoms, and social support

1 reference

12 December 2020

The epidemiology of depression in medical care

1 reference

12 December 2020

Severe mental illness and HIV-related medical and neuropsychiatric sequelae

1 reference

12 December 2020

Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states.

1 reference

12 December 2020

The neuropsychological aspects of HIV-1 spectrum disease

1 reference

12 December 2020

Didanosine: an updated review of its use in HIV infection

1 reference

12 December 2020

Depression and drug use impact health status among marginally housed HIV-infected individuals

1 reference

12 December 2020

Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.

1 reference

12 December 2020

Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone.

1 reference

12 December 2020

Manic syndrome associated with zidovudine treatment

1 reference

12 December 2020

Epidemiology and relative toxicity of antidepressant drugs in overdose

1 reference

12 December 2020

The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study

1 reference

12 December 2020

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

12 December 2020

Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease

1 reference

12 December 2020

HIV disease progression: depression, stress, and possible mechanisms

1 reference

12 December 2020

Completeness of response and quality of life in mood and anxiety disorders

1 reference

12 December 2020

Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study

1 reference

12 December 2020

Adverse events from drug therapy for human immunodeficiency virus disease

1 reference

12 December 2020

Dextroamphetamine as a treatment for depression and low energy in AIDS patients: a pilot study

1 reference

12 December 2020

Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugs

1 reference

12 December 2020

New directions in the treatment of antidepressant-induced sexual dysfunction

1 reference

12 December 2020

Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders

1 reference

12 December 2020

Meta-analysis of the relationship between HIV infection and risk for depressive disorders

1 reference

12 December 2020

Management of SSRI-induced sexual dysfunction

1 reference

12 December 2020

The 'usual care' of major depression in primary care practice.

1 reference

12 December 2020

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

12 December 2020

Human immunodeficiency virus-associated dementia

1 reference

12 December 2020

Efavirenz: practicalities, considerations and new issues.

1 reference

12 December 2020

The effect of changes in depression on health related quality of life (HRQoL) in HIV infection

1 reference

12 December 2020

Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial.

1 reference

12 December 2020

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

1 reference

12 December 2020

Manic syndrome associated with zidovudine

1 reference

12 December 2020

Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses.

1 reference

12 December 2020

Management of psychiatric disorders in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

1 reference

12 December 2020

The effectiveness of psychiatric treatment for HIV-infected patients

1 reference

12 December 2020

Depression severity and drug injection HIV risk behaviors

1 reference

12 December 2020

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

1 reference

12 December 2020

After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression

1 reference

12 December 2020

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

1 reference

12 December 2020

Underdiagnosis of depression in HIV: who are we missing?

1 reference

12 December 2020

Mood disorders in HIV infection

1 reference

12 December 2020

Treatment of depression in HIV-infected patients.

1 reference

12 December 2020

Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence

1 reference

12 December 2020

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020

Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine

1 reference

12 December 2020

Psychiatric illness predicts poor outcome after surgery for hip fracture: a prospective cohort study

1 reference

12 December 2020

Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression

1 reference

12 December 2020

Suicidal ideation among psychiatric patients with HIV: psychiatric morbidity and quality of life

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

1 reference

12 December 2020

Zidovudine toxicity. Clinical features and management

1 reference

12 December 2020

A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. II. Psychological and health status at baseline and at 12-month follow-up.

1 reference

12 December 2020

Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Depressive symptoms decline among persons on HIV protease inhibitors.

1 reference

12 December 2020

Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group

1 reference

12 December 2020

Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging

1 reference

12 December 2020

Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series

1 reference

12 December 2020

Efficacy of paroxetine for the treatment of depression in the context of HIV infection.

1 reference

12 December 2020

Evaluation and treatment of psychiatric disorders associated with HIV infection.

1 reference

12 December 2020

Effect of fluoxetine on pharmacokinetics of ritonavir.

1 reference

12 December 2020

An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir

1 reference

12 December 2020

Significant interactions with new antiretrovirals and psychotropic drugs.

1 reference

12 December 2020

Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.

1 reference

12 December 2020

Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.

1 reference

12 December 2020

Depression in medical outpatients. Underrecognition and misdiagnosis

1 reference

12 December 2020

Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women

1 reference

12 December 2020

A novel augmentation strategy for treating resistant major depression

1 reference

12 December 2020

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence

1 reference

12 December 2020

Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine

1 reference

12 December 2020

Self-reported oral dryness and HIV disease in a national sample of patients receiving medical care

1 reference

12 December 2020

Zidovudine-related mania.

1 reference

12 December 2020

Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.

1 reference

12 December 2020

Antidepressant treatment of depression in HIV-seropositive women

1 reference

12 December 2020

Psychiatric morbidity on entry to an HIV primary care clinic

1 reference

12 December 2020

Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia

1 reference

12 December 2020

Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation

1 reference

12 December 2020

Mirtazapine for depression in patients with human immunodeficiency virus

1 reference

12 December 2020

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

1 reference

12 December 2020

Neurologic and psychiatric complications of antiretroviral agents

1 reference

12 December 2020

Quality of life in depression and anxiety disorders: an exploratory follow-up study after intensive inpatient cognitive behaviour therapy.

1 reference

12 December 2020

Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance

1 reference

12 December 2020

Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion

1 reference

12 December 2020

Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.

1 reference

12 December 2020

10.2165/00002018-200528090-00002

Identifiers

DOI

1 reference

PubMed ID

16119970

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16119970